cell therapy manufacturing

james hebrew July 13, 2022

The approval of KYMIRAH®, YESCARTA®, Alofisel® and Zyntelgo® has increased the interest of pharma stakeholders in cell therapies; further, owing to the technical challenges in this field, outsourcing manufacturing operations has become a necessity.   Roots Analysis has announced the addition of “Cell Therapy Manufacturing market (3rd Edition), 2019 – 2030” report to its list […]